GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee

GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee


July 18th, 2025 – NEW YORK, United States

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advisor and digital asset treasury manager.

The $100 million private investment in public equity (PIPE) into MEI represents a significant step toward institutionalizing Litecoin as a treasury asset.

GSR will work closely with Litecoin (LTC) creator Charlie Lee, who brings deep technical credibility and a long-term perspective on Litecoin’s evolution, with support from the Litecoin Foundation. Lee and a GSR appointee will also join MEI’s Board of Directors. This initiative follows MEI’s previously announced review of strategic alternatives and reflects its new mission in

Trending: We Asked AI Who Wrote the Fake Trump-Epstein Note, And the Answer It Gave Blew Our Minds

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!